{
  "slug": "novogene",
  "name": "Novogene",
  "description": "Novogene is a leading global provider of Next-Generation Sequencing (NGS) and multi-omics services, offering superior data quality and high-throughput solutions for research and clinical diagnostics. They specialize in mRNA sequencing, single-cell sequencing, whole-genome sequencing, epigenome sequencing, proteomics, and metabolomics, utilizing state-of-the-art platforms from major technology providers.",
  "url": "https://optimly.ai/brand/novogene",
  "websiteUrl": null,
  "logoUrl": "https://logo.clearbit.com/https://www.novogene.com/us-en/",
  "baiScore": 54,
  "bai_tier_status": "active",
  "bai_score_status": "active",
  "archetype": "Challenger",
  "archetype_status": "active",
  "category": "Biotechnology",
  "categorySlug": null,
  "keyFacts": [],
  "aiReadiness": [],
  "competitors": [],
  "competitorsProse": null,
  "inboundCompetitors": [],
  "aiAlternatives": [],
  "parentBrand": null,
  "subBrands": [],
  "updatedAt": "2026-07-26T00:03:00.718Z",
  "verifiedVitals": {
    "website": "https://www.novogene.com/us-en/",
    "founded": "Not specified in the provided text.",
    "headquarters": "United States (California, Oregon), with global operations in UK, Germany, Netherlands, Singapore, Japan, Korea, Thailand, and China.",
    "pricing_model": "Service-based, project-based with advertised competitive rates (e.g., as low as $1,999/Sample for 10x Single Cell RNA-seq; $3,399 per wafer for Ultima Genomics Platform).",
    "core_products": "Genome Sequencing, Transcriptome Sequencing (mRNA, Single Cell RNA-seq), Epigenome Sequencing, Pre-made Library Sequencing, Proteomics & Metabolomics, Clinical Whole Exome Sequencing, Clinical Panels.",
    "key_differentiator": "Speed (fast turnaround times like 5-day mRNA sequencing), comprehensive multi-omics services, competitive pricing, utilization of state-of-the-art sequencing platforms (Illumina, Ultima, PacBio, Oxford Nanopore, 10x Genomics), and the FALCON automated intelligent delivery system.",
    "target_markets": "Research institutions, academic laboratories, pharmaceutical and biotechnology companies, clinical diagnostic providers, and individual researchers globally.",
    "employee_count": "Not specified in the provided text.",
    "funding_stage": "Not specified in the provided text.",
    "subcategory": "Next-Generation Sequencing (NGS) Services"
  },
  "intentTags": {
    "problemIntents": [
      "In-house genomics lab setup: Researchers or institutions would need to invest in their own sequencing equipment, reagents, and hire/train staff for library preparation, sequencing, and bioinformatics ",
      "Academic or institutional core facilities: Utilizing sequencing services provided by university core labs or other non-commercial institutional facilities, which might have specialized expertise but p",
      "Third-party bioinformatics software & services: Generating raw sequencing data either in-house or through a basic service, then using separate third-party software or specialized bioinformatics consul",
      "Relying on traditional molecular biology techniques: Continuing to use older, lower-throughput molecular biology methods (e.g., qPCR, Sanger sequencing for limited targets) instead of adopting compreh"
    ],
    "solutionIntents": [
      "Novogene mRNA sequencing",
      "Novogene single cell RNA-seq",
      "Novogene proteomics",
      "Novogene whole genome sequencing",
      "Novogene clinical diagnostics",
      "NGS service provider"
    ],
    "evaluationIntents": [
      "Novogene pricing"
    ]
  },
  "timestamp": 1785236440790
}